2226534-49-0
2226534-49-0
Chemical Structure
Y06137
- CAS No.: 2226534-49-0
- Formula:C27H32N4O2
- Molecular Weight:444.57
IUPAC Name: (S)-5-(1-(cyclohexylmethyl)-6-(3-methylmorpholino)-1H-benzo[d]imidazol-2-yl)-3-methylbenzo[d]isoxazole
InChIKey: JYCNBHVRGVCHIQ-SFHVURJKSA-N
SMILES: CC1=NOC(C1=C2)=CC=C2C3=NC(C=C4)=C(N3CC5CCCCC5)C=C4N6CCOC[C@@H]6C
Biological Activity: Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a Kd of 81 nM[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Y06137 | 98.39% | Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a Kd of 81 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Y06137 (Standard) | ≥98% | Y06137 (Standard) is the analytical standard of Y06137 (HY-111503). This product is intended for research and analytical applications. Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC). Y06137 binds to the BRD4(1) bromodomain with a Kd of 81 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
